PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Prostate Cancer
Interventions
DRUG

11C-Choline

11C-choline (0.05-0.1mCi/kg) was injected intravenously one week before or after the \[68Ga\]P137 PET/CT examination, and imaging of the head and body cadres was performed 20 min after the injection using Philips Gemini TF16 or Siemens Biograph M-CT flow PET/CT

Trial Locations (1)

100142

Beijing Cancer Hospital, Beijing

All Listed Sponsors
lead

Peking University Cancer Hospital & Institute

OTHER